<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Surg</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Surg</journal-id>
      <journal-title-group>
        <journal-title>BMC Surgery</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2482</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25927963</article-id>
      <article-id pub-id-type="pmc">4409735</article-id>
      <article-id pub-id-type="publisher-id">31</article-id>
      <article-id pub-id-type="doi">10.1186/s12893-015-0031-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Nonfunctional adrenocortical carcinoma initially presenting as retroperitoneal hemorrhage</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kashiwagi</surname>
            <given-names>Shinichiro</given-names>
          </name>
          <address>
            <email>spqv9ke9@view.ocn.ne.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amano</surname>
            <given-names>Ryosuke</given-names>
          </name>
          <address>
            <email>ramano@med.osaka-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Onoda</surname>
            <given-names>Naoyoshi</given-names>
          </name>
          <address>
            <email>nonoda@med.osaka-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Noda</surname>
            <given-names>Satoru</given-names>
          </name>
          <address>
            <email>s-noda@med.osaka-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hirata</surname>
            <given-names>Keiichiro</given-names>
          </name>
          <address>
            <email>hira-kei.0421@hotmail.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Asano</surname>
            <given-names>Yuka</given-names>
          </name>
          <address>
            <email>asnyk0325@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kurata</surname>
            <given-names>Kento</given-names>
          </name>
          <address>
            <email>kent6124@ybb.ne.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miura</surname>
            <given-names>Koutaro</given-names>
          </name>
          <address>
            <email>rockcrazy_05km12@msn.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamazoe</surname>
            <given-names>Sadaaki</given-names>
          </name>
          <address>
            <email>zoesada@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kimura</surname>
            <given-names>Kenjiro</given-names>
          </name>
          <address>
            <email>kenjiro@med.osaka-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ohsawa</surname>
            <given-names>Masahiko</given-names>
          </name>
          <address>
            <email>m-ohsawa@med.osaka-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kitagawa</surname>
            <given-names>Seiichi</given-names>
          </name>
          <address>
            <email>kitagawas@med.osaka-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hirakawa</surname>
            <given-names>Kosei</given-names>
          </name>
          <address>
            <email>hirakawa@med.osaka-cu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku Osaka, 545-8585 Japan </aff>
        <aff id="Aff2"><label/>Department of Diagnostic Pathology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku Osaka, 545-8585 Japan </aff>
        <aff id="Aff3"><label/>Department of Physiology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku Osaka, 545-8585 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>46</elocation-id>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Kashiwagi et al.; licensee BioMed Central. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Acute adrenal hemorrhage is an uncommon entity. Although trauma is the most common cause of adrenal hemorrhage, non-traumatic etiologies have also been reported. We report an unusual case of a spontaneously ruptured adrenocortical carcinoma that initially presented as a critical massive retroperitoneal hemorrhage. The case was treated successfully using a combination of emergency interventional radiology and elective surgery.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 47-year-old woman was transported to our hospital because of the sudden onset of severe pain in her left lower back. The shadow of a tumor-like soft mass accompanied by bleeding was observed in the upper pole of the left kidney, together with vascular leakage from the middle suprarenal artery on computed tomography. Transcatheter embolization of the left middle adrenal artery was administered based on a diagnosis of acute adrenal hemorrhage. Further observation indicated that the bleeding was caused by rupture of an adrenocortical carcinoma. Left adrenalectomy was subsequently carried out via laparotomy.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We experienced an unusual case of acute massive adrenal hemorrhage caused by the rupture of a non-functional adrenocortical carcinoma, which was treated successfully by ambulatory transcatheter embolization therapy and elective surgery.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Adrenocortical carcinoma</kwd>
        <kwd>Retroperitoneal hemorrhage</kwd>
        <kwd>Mitotane</kwd>
        <kwd>Interventional radiology</kwd>
        <kwd>Surgery</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Adrenocortical carcinoma is an uncommon disease, accounting for approximately 0.02% of all malignant tumors [<xref ref-type="bibr" rid="CR1">1</xref>-<xref ref-type="bibr" rid="CR3">3</xref>]. This tumor often exhibits endocrine activity, commonly in association with Cushing&#x2019;s syndrome, because of excessive secretion of cortisol from the tumor cells. Nevertheless, non-functional tumors are also occasionally detected [<xref ref-type="bibr" rid="CR1">1</xref>-<xref ref-type="bibr" rid="CR3">3</xref>]. About 30% of adrenocortical carcinomas are diagnosed incidentally during imaging procedures for unrelated medical issues [<xref ref-type="bibr" rid="CR4">4</xref>]. However, the asymptomatic nature of the tumor means that diagnosis is often delayed, and such lesions are therefore usually found only after the disease has progressed to an advanced stage, resulting in a poor outcome. Acute adrenal hemorrhage mostly occurs within adrenal tumors and the adrenal glands, often resulting in the formation of massive hematomas extending into the retroperitoneum, in association with urgent symptoms such as lower back pain, acute adrenal crisis, circulatory failure, and shock [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref>]. Anticoagulant therapy is a potential predisposing factor, but was not relevant to the present case [<xref ref-type="bibr" rid="CR7">7</xref>]. In addition, we can leave when both adrenal hemorrhage compares it if unilateral, and adrenal insufficiency is easy to be caused [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>We report an unusual case of a spontaneously ruptured, non-functional adrenocortical carcinoma that initially presented as a critical massive retroperitoneal hemorrhage, and which was successfully treated by a combination of emergency interventional radiology and elective surgery.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 47-year-old woman was transported to our hospital because of the sudden onset of severe pain in her left lower back. She was alert and conscious, with a blood pressure of 165/95&#xA0;mmHg, pulse of 77 beats/minute, and oxygen saturation of 95%. She appeared to be in distress and complained of sharp spontaneous pain in her left lower back. She was 162.0&#xA0;cm tall and weighed 84.5&#xA0;kg. There were no physical features suggestive of Cushing&#x2019;s syndrome. The patient had been healthy with no particular past medical history or familial disease. Her white blood cell count was 11,800/&#x3BC;L and her hemoglobin level was 8.8&#xA0;g/dL. Other than these findings, biochemical tests and urinalysis on admission demonstrated no particular abnormalities (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Emergency contrast-enhanced computed tomography (CT) of the abdomen revealed a tumor-like soft mass accompanied by massive bleeding in the retroperitoneum on the upper pole of the left kidney, in addition to vascular leakage from the middle suprarenal artery (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a, b). Immediately after obtaining the results of the CT scan, transcatheter embolization therapy of the left middle adrenal artery was performed based on a diagnosis of acute adrenal hemorrhage, possibly from a ruptured adrenal tumor (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>a, b). The patient&#x2019;s condition subsequently stabilized and a detailed investigation of the cause of the adrenal hemorrhage was initiated. Magnetic resonance imaging (MRI) revealed a hematoma expanded within the Gerota&#x2019;s fascia, and a round tumor was detected in addition to the hematoma, with a rich vasculature and possible necrotic area (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a, b). No liver nodules or swelling of the retroperitoneal lymph nodes suggestive of metastasis were observed. Endocrine function of the adrenal gland appeared normal. The above findings indicated a ruptured non-functional adrenocortical tumor. Imaging confirmed the absence of metastatic lesions, and the tumor was removed by elective laparotomy surgery 2&#xA0;months later. Regarding the surgical findings, no hemorrhage or abnormal adhesion was observed in the abdominal cavity. A soft elastic tumor measuring 10&#xA0;cm was palpable in the retroperitoneum at the inferior border of the pancreatic body. Although it adhered closely to the surrounding retroperitoneal fatty tissue, the tumor was removed <italic>en bloc</italic> by partially excising Gerota&#x2019;s fascia, without leaving any remnants. No invasion into the surrounding organs, lymph node metastasis, or liver metastasis was observed. The operative time was 229&#xA0;min, and the surgical blood loss was approximately 500&#xA0;mL. The patient recovered uneventfully. The tumor measured 13.5&#x2009;&#xD7;&#x2009;8.6&#x2009;&#xD7;&#x2009;4.2&#xA0;cm and weighed 380&#xA0;g. The cut surface indicated a yellowish solid tumor, with areas of bleeding accompanied by necrosis in a branched pattern (Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a, b). The normal adrenal gland could not be identified visually. Histopathological examination revealed proliferated tumor cells with an atypical morphology, with an eosinophilic or clear cytoplasm and large nucleus containing a distinct nucleolus (Figure&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a, b). Nuclear atypia and abundant nuclear mitotic images were observed (&#x2265;11 per 50 high-power fields (HPF)). A wide focus of necrosis was also noted, although there was no apparent invasion outside the capsule. The final diagnosis was a ruptured, non-functioning left adrenocortical carcinoma, pT2N0M0, stage II. Mitotane administration for 2&#xA0;years was planned as adjuvant therapy. The patient was alive at 6&#xA0;months after surgery, with no serious adverse events or relapse.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Laboratory data on admission</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th colspan="2">
<bold>&#x3010;Blood count&#x3011;</bold>
</th><th colspan="3">
<bold>&#x3010;Tumor marker&#x3011;</bold>
</th></tr></thead><tbody><tr valign="top"><td>WBC</td><td>11,800/&#x3BC;l</td><td>CEA</td><td colspan="2">1.6&#xA0;ng/ml</td></tr><tr valign="top"><td>RBC</td><td>303&#x2009;&#xD7;&#x2009;10<sup>4</sup> /&#x3BC;l</td><td>CA19-9</td><td colspan="2">18 U/ml</td></tr><tr valign="top"><td>Hb</td><td>8.8&#xA0;g/dl</td><td/><td colspan="2"/></tr><tr valign="top"><td>Hct</td><td>26.6%</td><td/><td colspan="2"/></tr><tr valign="top"><td>PLT</td><td>21.8&#x2009;&#xD7;&#x2009;10<sup>4</sup> /&#x3BC;l</td><td/><td colspan="2"/></tr><tr valign="top"><td colspan="2">
<bold>&#x3010;Blood chemistry&#x3011;</bold>
</td><td>
<bold>&#x3010;Endocrinology&#x3011;</bold>
</td><td/><td>(normal range)</td></tr><tr valign="top"><td>TP</td><td>7.1&#xA0;g/dl</td><td>Vanillymandelic acid</td><td>8.0&#xA0;ng/ml</td><td>(3.3&#x2009;~&#x2009;8.6)</td></tr><tr valign="top"><td>Alb</td><td>4.1&#xA0;g/dl</td><td>Adrenaline</td><td>&lt;0.01&#xA0;ng/ml</td><td>(0.00&#x2009;~&#x2009;0.17)</td></tr><tr valign="top"><td>AST</td><td>13&#xA0;IU/l</td><td>Nor-Adrenaline</td><td>0.42&#xA0;ng/ml</td><td>(0.15&#x2009;~&#x2009;0.57)</td></tr><tr valign="top"><td>ALT</td><td>13&#xA0;IU/l</td><td>Dopamine</td><td>&lt;0.02&#xA0;ng/ml</td><td>(0.00&#x2009;~&#x2009;0.03)</td></tr><tr valign="top"><td>ALP</td><td>262&#xA0;IU/l</td><td>Cortisol</td><td>9.2&#xA0;&#x3BC;g/dl</td><td>(4.0&#x2009;~&#x2009;19.3)</td></tr><tr valign="top"><td>LDH</td><td>137&#xA0;IU/l</td><td>ACTH</td><td>46.9&#xA0;pg/ml</td><td>(7.2&#x2009;~&#x2009;63.3)</td></tr><tr valign="top"><td>T-Bil</td><td>0.5&#xA0;mg/dl</td><td>DHEA-S</td><td>225&#xA0;&#x3BC;g/dl</td><td>(33&#x2009;~&#x2009;262)</td></tr><tr valign="top"><td>BUN</td><td>9&#xA0;mg/dl</td><td/><td/><td/></tr><tr valign="top"><td/><td/><td>
<bold>&#x3010;Urinary Cathecolamine&#x3011;</bold>
</td><td/><td>(normal range)</td></tr><tr valign="top"><td>Cre</td><td>0.88&#xA0;mg/dl</td><td>Vanillymandelic acid</td><td>3.5&#xA0;mg/day</td><td>(1.4&#x2009;~&#x2009;4.9)</td></tr><tr valign="top"><td>Na</td><td>142&#xA0;mEq/l</td><td>Adrenaline</td><td>12.1&#xA0;&#x3BC;g/day</td><td>(1.0&#x2009;~&#x2009;23.0)</td></tr><tr valign="top"><td>K 4.</td><td>0&#xA0;mEq/l</td><td>Nor-Adrenaline</td><td>94.2&#xA0;&#x3BC;g/day</td><td>(29&#x2009;~&#x2009;120)</td></tr><tr valign="top"><td>Cl</td><td>106&#xA0;mEq/l</td><td>Dopamine</td><td>260&#xA0;&#x3BC;g/day</td><td>(100&#x2009;~&#x2009;1000)</td></tr><tr valign="top"><td>Ca</td><td>8.9&#xA0;mEq/l</td><td>Metanephrine</td><td>0.11&#xA0;mg/day</td><td>(0.05&#x2009;~&#x2009;0.20)</td></tr><tr valign="top"><td>P</td><td>3.1&#xA0;mEq/l</td><td>Normetanephrine</td><td>0.19&#xA0;mg/day</td><td>(0.1&#x2009;~&#x2009;0.28)</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Figure 1</label><caption><p>Contrast-enhanced CT findings. <bold>a</bold>. Emergency contrast-enhanced CT of the abdomen revealed a tumor-like soft mass accompanied by massive bleeding in the retroperitoneum (Transverse plane). <bold>b</bold>. Coronal plane.</p></caption><graphic xlink:href="12893_2015_31_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>Transcatheter embolization therapy. <bold>a</bold>. The left middle adrenal artery was carried out under a diagnosis of acute adrenal hemorrhage (Before arterial embolization). <bold>b</bold>. After embolization.</p></caption><graphic xlink:href="12893_2015_31_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>MRI images findings. <bold>a</bold>. A tumor exhibiting non-uniform high to low signals on both T1 and T2 MRI images was observed in the left adrenal gland (Transverse plane). <bold>b</bold>. Coronal plane.</p></caption><graphic xlink:href="12893_2015_31_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Figure 4</label><caption><p>Resected specimen. <bold>a</bold>. The tumor measured in 13.5&#x2009;&#xD7;&#x2009;8.6&#x2009;&#xD7;&#x2009;4.2&#xA0;cm and weighed 380&#xA0;g. <bold>b</bold>. The cut surface was yellow and solid, and areas of bleeding accompanied by necrosis.</p></caption><graphic xlink:href="12893_2015_31_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Figure 5</label><caption><p>Histopathological findings. <bold>a</bold>. Histopathological findings. of solidly proliferating tumor cells showing an atypical morphology with an eosinophilic or clear cytoplasm and large nucleus containing a distinct nucleolus <bold>(</bold>Nuclear atypia: Fuhrman criteria Grade III). <bold>b</bold>. Arrow: atypical mitotic figures. (Hematoxylin and eosin staining&#x2009;&#xD7;&#x2009;400).</p></caption><graphic xlink:href="12893_2015_31_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>Adrenocortical carcinoma is an uncommon disease found in 0.5&#x2013;2 per million people, accounting for only 0.02% of all malignant tumors [<xref ref-type="bibr" rid="CR1">1</xref>-<xref ref-type="bibr" rid="CR3">3</xref>]. Approximately 40% of adrenocortical carcinomas have been reported to be non-functional [<xref ref-type="bibr" rid="CR1">1</xref>-<xref ref-type="bibr" rid="CR3">3</xref>]. In contrast, Cushing&#x2019;s syndrome is often present in cases of functioning tumors [<xref ref-type="bibr" rid="CR1">1</xref>], with dehydroepiandrosterone sulfate as a tumor marker. The prognosis of patients with adrenocortical carcinoma is poor, with a 5-year survival rate of 16&#x2013;35% [<xref ref-type="bibr" rid="CR8">8</xref>], largely attributable to the fact that approximately 80% of cases are discovered at an advanced stage [<xref ref-type="bibr" rid="CR9">9</xref>]. In the present case, however, although the tumor was large, no extracapsular invasion or metastasis had occurred and complete resection was accomplished successfully.</p>
      <p>CT and MRI are useful modalities for diagnosing adrenocortical carcinoma [<xref ref-type="bibr" rid="CR10">10</xref>-<xref ref-type="bibr" rid="CR12">12</xref>]. Tumors &#x2265;5&#xA0;cm are highly likely to be malignant, and non-uniform imaging effects/necrosis in the center accompanied by calcification have been reported to be a common finding of malignant tumors [<xref ref-type="bibr" rid="CR10">10</xref>]. Typical adrenocortical cancer presents with low signals on T1 intensity MRI images and non-uniform high signals on T2 intensity images [<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref>]. The diagnosis of non-functional adrenocortical carcinomas using adrenal cortex scintigraphy is generally regarded as difficult. However, Weiss criteria are often used to differentiate between malignant adrenocortical tumors and benign tumors pathologically [<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref>]. Nine criteria are assessed, including a high nuclear grade, &gt;5 mitoses per 50 HPF, atypical mitotic figures, &lt;25% clear cells, a diffuse architecture, necrosis, venous invasion, sinusoidal invasion, and capsular invasion. The diagnosis in the present case was made based on four criteria: nuclear grade, mitotic index, diffuse architecture, and necrosis.</p>
      <p>Surgical resection is the treatment of choice in patients with adrenocortical carcinoma, and survival can be prolonged significantly among patients able to undergo radical excision [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR14">14</xref>]. The steroidogenesis repressor mitotane is often used in cases of advanced disease, or as postoperative adjuvant therapy. Previous reports also found that the administration of postoperative adjuvant therapy following radical surgery prolonged relapse-free survival [<xref ref-type="bibr" rid="CR15">15</xref>]. However, no universal consensus has been reached regarding the efficacy of mitotane as adjuvant therapy [<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>Adrenal hemorrhage is an uncommon entity. Although trauma is the most common cause, non-traumatic etiologies have also been reported. Large and progressively growing tumorous lesions, such as adrenocortical carcinomas, pheochromocytomas, metastatic tumors, and myelolipomas, may carry a risk of tearing or rupture, either alone or in combination with hemorrhagic diathesis, stress, or other idiopathic causes [<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref>]. Massive adrenal hemorrhage remains rare. With respect to its treatment, follow-up is therefore often sufficient if the patient&#x2019;s systemic condition is stable and findings for tumorous lesions are negative [<xref ref-type="bibr" rid="CR17">17</xref>]. However, if the patient&#x2019;s systemic condition is unstable or bleeding from a tumorous lesion is suspected, as in the current case, adrenalectomy, including the hematoma, is required [<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref>]. The effective application of transcatheter embolization therapy has been reported, including in the present case, suggesting its potential value in patients with an unstable systemic condition [<xref ref-type="bibr" rid="CR19">19</xref>-<xref ref-type="bibr" rid="CR21">21</xref>].</p>
      <p>We experienced an unusual case of acute massive adrenal hemorrhage caused by the rupture of a non-functional adrenocortical carcinoma, which was treated successfully with ambulatory transcatheter embolization therapy and elective surgery.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>We experienced an unusual case of acute massive adrenal hemorrhage caused by the rupture of a non-functional adrenocortical carcinoma, which was treated successfully by ambulatory transcatheter embolization therapy and elective surgery.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report, including the associated images.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>CT</term>
          <def>
            <p>computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>magnetic resonance imaging</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>All authors were involved in the preparation of this manuscript. SKa performed the operation, collected the data, and wrote the manuscript. RA, NO, SN, and KHi performed the operation and designed the study. YA, KKu, and KM summarized the data and revised the manuscript. SY and KKi performed the operation and collected the data. MO, SKi, and KHi made substantial contributions to the study design, performed the operation, and revised the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>We thank Sayaka Tanaka (Department of Diagnostic Pathology, Osaka City University Graduate School of Medicine) for helpful advice regarding pathological evaluation.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Else</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Sabolch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Kandathil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Caoili</surname>
              <given-names>EM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adrenalcortical carcinoma</article-title>
          <source>Endocrine Rev</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>282</fpage>
          <lpage>326</lpage>
          <pub-id pub-id-type="doi">10.1210/er.2013-1029</pub-id>
          <pub-id pub-id-type="pmid">24423978</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linda</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Libertino</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Adrenalcortical carcinoma: diagnosis, evaluation and treatment</article-title>
          <source>J Urol</source>
          <year>2003</year>
          <volume>169</volume>
          <fpage>5</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">12478091</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dackiw</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Gagel</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Adrenal cortical carcinoma</article-title>
          <source>World J Surg</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>914</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1007/s00268-001-0030-7</pub-id>
          <pub-id pub-id-type="pmid">11572033</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Clinical management of adrenocortical carcinoma</article-title>
          <source>Best Pract Res Clin Endocrinol Metabol</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>273</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1016/j.beem.2008.10.008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luton</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Cerdas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Billaud</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guilhaume</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bertagna</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy</article-title>
          <source>N Engl J Med</source>
          <year>1990</year>
          <volume>322</volume>
          <fpage>1195</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199004263221705</pub-id>
          <pub-id pub-id-type="pmid">2325710</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Hammer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Else</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of adrenocortical carcinoma</article-title>
          <source>Adrenocortical Carcinoma</source>
          <year>2010</year>
          <edition>1</edition>
          <publisher-loc>New York, NY</publisher-loc>
          <publisher-name>Springer</publisher-name>
          <fpage>23</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDonald</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Pardo</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Adrenal haemorrhage during anticoagulant therapy</article-title>
          <source>JAMA</source>
          <year>1996</year>
          <volume>198</volume>
          <fpage>1052</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.1966.03110230068014</pub-id>
          <pub-id pub-id-type="pmid">5953381</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulick</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma</article-title>
          <source>Ann Surg Oncol</source>
          <year>1999</year>
          <volume>6</volume>
          <fpage>719</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1007/s10434-999-0719-7</pub-id>
          <pub-id pub-id-type="pmid">10622498</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stojadinovic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ghossein</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hoos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nissan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dudas</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adrenocortical carcinoma: clinical, morphologic, and molecular characterization</article-title>
          <source>J Clin Oncol</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>941</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.20.4.941</pub-id>
          <pub-id pub-id-type="pmid">11844815</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawashima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sandler</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Charnsangavej</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yasumori</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spectrum of CT findings in nonmalignant disease of the adrenal gland</article-title>
          <source>Radiographics</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>393</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="doi">10.1148/radiographics.18.2.9536486</pub-id>
          <pub-id pub-id-type="pmid">9536486</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawashima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sandler</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Roubidoux</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Imaging of nontraumatic hemorrhage of the adrenal gland</article-title>
          <source>Radiographics</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>949</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1148/radiographics.19.4.g99jl13949</pub-id>
          <pub-id pub-id-type="pmid">10464802</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlund</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Kenney</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Ascher</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Semelka</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Adrenocortical carcinoma: MR imaging appearance with current techniques</article-title>
          <source>J Magn Reson Imaging</source>
          <year>1995</year>
          <volume>5</volume>
          <fpage>171</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1002/jmri.1880050211</pub-id>
          <pub-id pub-id-type="pmid">7766978</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors</article-title>
          <source>Am J Surg Pathol</source>
          <year>1984</year>
          <volume>8</volume>
          <fpage>163</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-198403000-00001</pub-id>
          <pub-id pub-id-type="pmid">6703192</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Vickery</surname>
              <given-names>AL</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Pathologic features of prognostic significance in adrenocortical carcinoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>1989</year>
          <volume>13</volume>
          <fpage>202</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-198903000-00004</pub-id>
          <pub-id pub-id-type="pmid">2919718</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terzolo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Angeli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Daffara</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tauchmanova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Conton</surname>
              <given-names>PA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adjuvant mitotane treatment for adrenocortical carcinoma</article-title>
          <source>N Engl J Med</source>
          <year>2007</year>
          <volume>356</volume>
          <fpage>2372</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa063360</pub-id>
          <pub-id pub-id-type="pmid">17554118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wajchenberg</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Albergaria Pereira</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Medonca</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Latronico</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Campos Carneiro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>VA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adreno carcinoma : clinical and laboratory observations</article-title>
          <source>Cancer</source>
          <year>2000</year>
          <volume>88</volume>
          <fpage>711</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(20000215)88:4&lt;711::AID-CNCR1&gt;3.0.CO;2-W</pub-id>
          <pub-id pub-id-type="pmid">10679640</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kroiss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Update in adrenocortical carcinoma</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2013</year>
          <volume>98</volume>
          <fpage>4551</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2013-3020</pub-id>
          <pub-id pub-id-type="pmid">24081734</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pode</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Caine</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Spontaneous retroperitoneal hemorrhage</article-title>
          <source>J Urol</source>
          <year>1992</year>
          <volume>147</volume>
          <fpage>311</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">1346277</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bunuan</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Alltree</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Merendino</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Gel foam embolization of a functioning pheochromocytoma</article-title>
          <source>Am J Surg</source>
          <year>1978</year>
          <volume>136</volume>
          <fpage>395</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/0002-9610(78)90304-5</pub-id>
          <pub-id pub-id-type="pmid">707715</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Timmis</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Allison</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic embolization of phaeochromocytoma</article-title>
          <source>Br J Radiol</source>
          <year>1981</year>
          <volume>54</volume>
          <fpage>420</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="doi">10.1259/0007-1285-54-641-420</pub-id>
          <pub-id pub-id-type="pmid">7237014</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horton</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hrabovsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Klingberg</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Hostler</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic embolization of a hyperfunctioning pheochromocytoma</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>1983</year>
          <volume>140</volume>
          <fpage>987</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.2214/ajr.140.5.987</pub-id>
          <pub-id pub-id-type="pmid">6601448</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
